More novel biomarkers, such as sST2, galectin-3, TIMP1, and secretoneurin, have shown promise in predicting adverse outcomes more specifically related to cardiac dysfunction in sepsis [47–56, 89]. The gene discussed is SCG2; the disease is Sepsis.